NEW YORK (GenomeWeb) — Premaitha Health said today that it has filed a defense and counterclaim in response to Illumina's patent infringement lawsuit against the firm in the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.